Our take on the latest news and views on data.
Relevant company news, articles, podcasts, and blog posts.
Recent Posts
New Developments in Alzheimer’s Treatment
OZMOSI’s predictions for where Alzheimer's treatment is headed. The Ravaging Effects of Alzheimer’s The devastation of living...
The Clinical Trial Powershift
Pharmaceutical companies are being pushed aside when it comes to who is driving clinical outcomes. Despite the growing number of...
China Reshaping the Clinical Trial Pipeline
Finally, the data is in here at OZMOSI, and we can start tracking and reporting on the clinical development expected to come out...
Industry Trends
Using NLP Data to Classify Patient Segments in Clinical Trial Data
One of the most common and powerful approaches in NLP provides the content experts an opportunity to label each data segment for...
Letting the Data Tell the Story
In our previous post we described the technique for assigning categories to data, based on input from content experts within a...
When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency
Predicting when a competing product will be approved is essential in any commercial forecast and for any business insights team...
Clinical Trial Trends
Keeping up with the Pharmaceutical Industry in Asia
Keeping up with the pharmaceutical landscape around the world, especially in Asia, is essential in today’s market. Here are some...
Disease Area Trends
The Future of Innovation in Diabetes & Heart Disease
When it comes to improving the lives of patients with chronic illnesses like type-2 diabetes and heart disease, the...
Recent Tweets
$MREO ATALANTa fully enrolled, status updated to Active, not recruiting. https://clinicaltrials.gov/ct2/show/NCT03679598
🔥Companies with important clinical readouts Coming soon📅
$RVMD RMC-4630 (SHP-2 Inhibitor) by Revolution Medicines in P2 - NCT05054725
$ESAIY Phenamil (ENaC Inhibitor,TRPP3 Inhibitor) by Eisai in P2 - NCT03477175
$MRTX Sitravatinib (RTK Inhibitor) by Mirati in P1 - NCT04518046
🧬 SPDR Biotech $XBI Movers Today 🩸
Top 3 XBI Gainers:
$IBRX (ImmunityBio) 9.37% 📈
$ARCT (Arcturus Ther.) 14.73% 📈
$YMAB (Y-mAbs Ther.) 59.88% 📈
Top 3 XBI Laggards:
$RNA (Avidity Bio) -8.3% 🔻
$VBIV (VBI Vaccines) -2.4% 🔻
$AKBA (Akebia Ther.) -2.2% 🔻
Get Started with OZMOSI
We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.
600 Warren Ave,
Spring Lake, NJ 07762